Substituted quinazoline derivatives as inhibitors of aurora...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S284000

Reexamination Certificate

active

10499684

ABSTRACT:
The invention provides quinazoline derivatives of formula (I): in the preparation of a medicament for use in the inhibition of Aurora kinase and also novel quinazoline derivatives, processes for their preparation, pharamceutical compositions containing them and their use in therapy

REFERENCES:
patent: 5480883 (1996-01-01), Spada et al.
patent: 5710158 (1998-01-01), Myers et al.
patent: 6610677 (2003-08-01), Davies et al.
patent: 0326330 (2002-07-01), None
patent: WO-92/20642 (1992-11-01), None
patent: WO-95/15758 (1995-06-01), None
patent: 96/09294 (1996-03-01), None
patent: 96/15118 (1996-05-01), None
patent: 96/39145 (1996-12-01), None
patent: WO-96/39145 (1996-12-01), None
patent: WO-97/03069 (1997-01-01), None
patent: 99/06378 (1999-02-01), None
patent: 00/21955 (2000-04-01), None
patent: 00/21955 (2000-04-01), None
patent: WO-00/21955 (2000-04-01), None
patent: 01/21596 (2001-03-01), None
patent: 01/21596 (2001-03-01), None
patent: 01/21597 (2001-03-01), None
patent: WO-01/21597 (2001-03-01), None
patent: 02/00649 (2002-01-01), None
patent: WO-02/00649 (2002-01-01), None
Wilkinson et al., “AZD1152, a Selective Inhibitor of Aurora B Kinase, Inhibits Human Tumor Xenograft Growth by Including Apoptosis”, Clinical CAncer REsearch (2007), 3682-3688, 13(12).
Mortlock et al., “Discovery, Synthesis, and in Vivo Activity of a New Class of Pyrazolylaminoquinazolines as Selective Inhibitors of Aurora B Kinase”. Journal of Medicinal Chemistry (2007), 2213-2224, 50(9).
Heron et al., “SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors”. Bioorganic & Medicinal Chemistry Letters (2006), 1320-1323, 16(5).
Jung et al., “Discovery of Novel and Potent Thiazoloquinazolines as Selective Aurora A and B Kinase Inhibitors”. Journal of Medicinal Chemistry (2006), 955-970, 49(3).
Mortlock et al., “Progress in the Development of Selective Inhibitors of Aurora Kinases”. Current Topics in Medicinal Chemistry (2005), 807-821, 5(8).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Substituted quinazoline derivatives as inhibitors of aurora... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted quinazoline derivatives as inhibitors of aurora..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted quinazoline derivatives as inhibitors of aurora... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3914524

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.